These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29802930)

  • 1. Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma.
    González-Fernández Y; Brown HK; Patiño-García A; Heymann D; Blanco-Prieto MJ
    Cancer Lett; 2018 Aug; 430():193-200. PubMed ID: 29802930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squalenoyl-gemcitabine/edelfosine nanoassemblies: Anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice.
    Rodríguez-Nogales C; Mura S; Couvreur P; Blanco-Prieto MJ
    Int J Pharm; 2020 May; 582():119345. PubMed ID: 32311470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells.
    González-Fernández Y; Imbuluzqueta E; Zalacain M; Mollinedo F; Patiño-García A; Blanco-Prieto MJ
    Cancer Lett; 2017 Mar; 388():262-268. PubMed ID: 27998763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
    Tan ML; Friedhuber AM; Dass CR
    J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo efficacy of edelfosine-loaded lipid nanoparticles against glioma.
    Estella-Hermoso de Mendoza A; Préat V; Mollinedo F; Blanco-Prieto MJ
    J Control Release; 2011 Dec; 156(3):421-6. PubMed ID: 21821074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin and CD‑CUR inclusion complex co‑loaded in thermosensitive hydrogel PLGA‑PEG‑PLGA localized administration for osteosarcoma.
    Yang Z; Liu J; Lu Y
    Int J Oncol; 2020 Aug; 57(2):433-444. PubMed ID: 32468050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles protect from edelfosine toxicity in vivo.
    Lasa-Saracíbar B; Aznar MÁ; Lana H; Aizpún I; Gil AG; Blanco-Prieto MJ
    Int J Pharm; 2014 Oct; 474(1-2):1-5. PubMed ID: 25091376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of edelfosine lipid nanoparticles in breast cancer cells.
    Aznar MÁ; Lasa-Saracíbar B; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
    Int J Pharm; 2013 Oct; 454(2):720-6. PubMed ID: 23643510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma.
    Xia YZ; Yang L; Xue GM; Zhang C; Guo C; Yang YW; Li SS; Zhang LY; Guo QL; Kong LY
    Oncotarget; 2016 Aug; 7(35):56371-56382. PubMed ID: 27486760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines.
    Lasa-Saracíbar B; Estella-Hermoso de Mendoza A; Mollinedo F; Odero MD; Blanco-Príeto MJ
    Cancer Lett; 2013 Jul; 334(2):302-10. PubMed ID: 23353057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic osteosarcoma.
    Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
    Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
    Feng S; Wu ZX; Zhao Z; Liu J; Sun K; Guo C; Wang H; Wu Z
    ACS Appl Mater Interfaces; 2019 Feb; 11(7):7357-7368. PubMed ID: 30682240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional bone cement for synergistic magnetic hyperthermia ablation and chemotherapy of osteosarcoma.
    Liang B; Zuo D; Yu K; Cai X; Qiao B; Deng R; Yang J; Chu L; Deng Z; Zheng Y; Zuo G
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110460. PubMed ID: 31923975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of anticancer efficacy of drug loaded cockle shell-derived aragonite nanoparticles.
    Wenliang F; Rameli MABP; Ibrahim TAT; Noor MHM; Yusof LM; Zakaria MZAB
    J Biomed Mater Res B Appl Biomater; 2019 Aug; 107(6):1898-1907. PubMed ID: 30597760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis.
    Gross AC; Cam H; Phelps DA; Saraf AJ; Bid HK; Cam M; London CA; Winget SA; Arnold MA; Brandolini L; Mo X; Hinckley JM; Houghton PJ; Roberts RD
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells.
    Chen F; Zeng Y; Qi X; Chen Y; Ge Z; Jiang Z; Zhang X; Dong Y; Chen H; Yu Z
    Nanomedicine; 2018 Oct; 14(7):2115-2127. PubMed ID: 29898423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.